GMED Stock: Price, Earnings History and SEC Filings
Globus Medical, Inc. (GMED) last traded at $78.05, down 5.86% on the latest session and up 4.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.34 against an analyst estimate of $1.12, a beat of 19.6%.
$78.05 -5.86%
1 month+4.21%
52-week high$101.40
52-week low$59.51
Volume1.68M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GMED earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $1.34 | $1.12 | +19.64% |
| Mar 2026 | May 7, 2026 | $1.12 | $0.92 | +21.74% |
| Dec 2025 | Feb 24, 2026 | $1.28 | $1.06 | +20.75% |
| Sep 2025 | Nov 6, 2025 | $1.18 | $0.79 | +49.37% |
GMED beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GMED
SEC filing data is not available right now. You can search for GMED on SEC EDGAR.
GMED news
- Is Globus Medical (GMED) Undervalued On Its Earnings Beat And Share Price Pullback?Oct 31, 2026 · finance.yahoo.com
- Globus Medical Stock Gains Attention After Earnings Beat And Continued GrowthOct 31, 2026 · finance.yahoo.com
- SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutOct 30, 2026 · finance.yahoo.com
- Alphatec Sinks 36% on Guidance Cut as Q3 Revenue Falls ShortOct 30, 2026 · tikr.com
- DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseOct 30, 2026 · finance.yahoo.com
- DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YOct 30, 2026 · finance.yahoo.com
- 2 cash-producing stocks with promising prospects and 1 we avoidOct 30, 2026 · finance.yahoo.com
- Reasons to Hold Hinge Health Stock in Your Portfolio for NowOct 29, 2026 · finance.yahoo.com
About Globus Medical, Inc.
Globus Medical, Inc. (GMED) is a US-listed public company on NYSE.